Confluent CFLT has been analyzed by 16 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 10 | 5 | 1 | 0 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 6 | 4 | 0 | 0 | 0 |
| 2M Ago | 2 | 0 | 0 | 0 | 0 |
| 3M Ago | 2 | 1 | 0 | 0 | 0 |
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $36.94, with a high estimate of $40.00 and a low estimate of $30.00. This current average reflects an increase of 7.73% from the previous average price target of $34.29.
Breaking Down Analyst Ratings: A Detailed Examination
In examining recent analyst actions, we gain insights into how financial experts perceive Confluent. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Kash Rangan | Goldman Sachs | Raises | Neutral | $30.00 | $27.00 |
| Matthew Hedberg | RBC Capital | Raises | Outperform | $40.00 | $37.00 |
| Raimo Lenschow | Barclays | Raises | Overweight | $34.00 | $33.00 |
| Patrick Walravens | JMP Securities | Raises | Market Outperform | $40.00 | $38.00 |
| Howard Ma | Guggenheim | Raises | Buy | $37.00 | $35.00 |
| Derrick Wood | TD Cowen | Raises | Buy | $37.00 | $34.00 |
| Michael Turrin | Wells Fargo | Raises | Overweight | $38.00 | $36.00 |
| Joel Fishbein | Truist Securities | Raises | Buy | $36.00 | $33.00 |
| Kingsley Crane | Canaccord Genuity | Raises | Buy | $35.00 | $28.00 |
| Mike Cikos | Needham | Maintains | Buy | $38.00 | - |
| Gregg Moskowitz | Mizuho | Lowers | Buy | $36.00 | $38.00 |
| Rudy Kessinger | DA Davidson | Maintains | Buy | $37.00 | $37.00 |
| Mike Cikos | Needham | Raises | Buy | $38.00 | $35.00 |
| Brad Reback | Stifel | Announces | Buy | $40.00 | - |
| Gregg Moskowitz | Mizuho | Raises | Buy | $38.00 | $34.00 |
| Matthew Hedberg | RBC Capital | Raises | Outperform | $37.00 | $35.00 |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Confluent. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Confluent compared to the broader market.
- Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Confluent's stock. This comparison reveals trends in analysts' expectations over time.
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Confluent's market standing. Stay informed and make well-considered decisions with our Ratings Table.
Stay up to date on Confluent analyst ratings.
All You Need to Know About Confluent
Confluent Inc is a new category of data infrastructure designed to connect all the applications, systems, and data layers of a company around a real-time central nervous system. Its products include Confluent Platform; Connectors; ksqlDB and others. The company generates revenue from the sale of subscriptions and services. Geographically, it derives a majority of its revenue from the United States. The company provides solutions to Financial Services; Insurance; Retail and eCommerce; Automotive; Government and other sectors.
Financial Milestones: Confluent's Journey
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Over the 3 months period, Confluent showcased positive performance, achieving a revenue growth rate of 26.39% as of 31 December, 2023. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: Confluent's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -44.14%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Confluent's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -11.77%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Confluent's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -3.9%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Confluent's debt-to-equity ratio is notably higher than the industry average. With a ratio of 1.37, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
How Are Analyst Ratings Determined?
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
